In HCC, a four-gene combination involving KIF4A, UBE2T, CDCA3, and CDCA5 can track disease progression from chronic active hepatitis B (CAH-B) and liver cirrhosis (LC) to HCC [117, 136]. This evidence concerns the gene CDCA5 and laryngotracheoesophageal cleft.